Nozomu Wada Selected Research

Nozomu Wada Research Topics

Disease

22	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2011
13	Neoplasms (Cancer) 03/2024 - 12/2014
6	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 01/2011
5	Fibrosis (Cirrhosis) 10/2023 - 01/2011
5	Non-alcoholic Fatty Liver Disease 08/2023 - 11/2015
4	Ascites 05/2021 - 01/2011
3	Infections 02/2019 - 04/2014
2	End Stage Liver Disease 10/2023 - 02/2019
2	Hyponatremia 05/2021 - 12/2020
2	Pain (Aches) 01/2019 - 12/2014
2	Chronic Hepatitis B 01/2019 - 01/2016
2	Alcoholic Fatty Liver 02/2016 - 03/2015
2	Obesity 02/2016 - 11/2015
1	Liver Neoplasms (Liver Cancer) 03/2024
1	Focal Nodular Hyperplasia 02/2022
1	Liver Failure 02/2022
1	Rupture 02/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Hyperaldosteronism (Conn Syndrome) 05/2021
1	Weight Loss (Weight Reduction) 12/2020
1	Dehydration (Water Stress) 12/2020
1	Pathologic Constriction (Stenosis) 12/2020
1	Edema (Dropsy) 12/2020
1	Autoimmune Hepatitis 08/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2019
1	Chronic Thyroiditis 08/2019
1	Vomiting 08/2019
1	Fever (Fevers) 08/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2019
1	Hepatitis B 02/2019
1	Hypophosphatemia 01/2019
1	Osteomalacia 01/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Coinfection 08/2018
1	Pulmonary Hypertension 05/2018
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 05/2018
1	Insulin Resistance 01/2017
1	Disease Progression 01/2017
1	Fatty Liver 02/2016
1	Cholangiocarcinoma 01/2016

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2015 - 04/2014
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2024 - 08/2016
3	SodiumIBA 10/2023 - 12/2020
3	CytokinesIBA 08/2023 - 01/2017
2	atezolizumabIBA 03/2024 - 01/2023
2	Bevacizumab (Avastin)FDA Link 03/2024 - 01/2023
2	DiureticsIBA 05/2021 - 01/2012
2	Tolvaptan FDA Link 05/2021 - 12/2020
2	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2021 - 01/2020
2	entecavir FDA Link 01/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2015
2	Messenger RNA (mRNA)IBA 01/2017 - 11/2015
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2016 - 01/2015
2	GadoliniumIBA 01/2016 - 01/2015
2	Polysaccharides (Glycans)IBA 09/2015 - 03/2015
2	BilirubinIBA 01/2012 - 01/2011
2	AlbuminsIBA 01/2012 - 01/2011
1	Becaplermin (PDGF-BB)FDA Link 08/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2023
1	Chemokine CCL5IBA 08/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2022
1	Serum AlbuminIBA 02/2022
1	Technetium (Technetium 99m)IBA 02/2022
1	Everolimus FDA Link 01/2022
1	Aquaporin 2IBA 05/2021
1	Natriuretic AgentsIBA 05/2021
1	Transaminases (Aminotransferases)IBA 05/2021
1	Circulating Tumor DNAIBA 04/2021
1	acarboxyprothrombin (PIVKA)IBA 04/2021
1	Furosemide (Lasix)FDA LinkGeneric 12/2020
1	Spironolactone (Aldactone)FDA LinkGeneric 12/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 12/2020
1	AntioxidantsIBA 08/2020
1	Prothrombin (Factor II)IBA 07/2020
1	Fetal Proteins (Fetoprotein)IBA 07/2020
1	SteroidsIBA 08/2019
1	Prednisolone (Predate)FDA LinkGeneric 08/2019
1	Sorafenib (BAY 43-9006)FDA Link 06/2019
1	VaccinesIBA 02/2019
1	Immunoglobulins (Immunoglobulin)IBA 02/2019
1	hepatitis B hyperimmune globulinIBA 02/2019
1	Alkaline PhosphataseIBA 01/2019
1	adefovir dipivoxil (Hepsera)FDA Link 01/2019
1	daclatasvirIBA 08/2018
1	asunaprevirIBA 08/2018
1	Therapeutic UsesIBA 10/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Sucrose (Saccharose)IBA 02/2016
1	Phosphatidylethanolamine N-MethyltransferaseIBA 02/2016
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2016

Therapy/Procedure

9	Radiofrequency Ablation 08/2020 - 01/2011
7	Therapeutics 03/2024 - 01/2016
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
3	Liver Transplantation 02/2022 - 05/2018
1	Induction Chemotherapy 03/2024